plerixafor has been researched along with Rhabdomyosarcoma 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barr, FG; Drukala, J; Grymula, K; Kucia, M; Ratajczak, J; Ratajczak, MZ; Tarnowski, M; Wysoczynski, M | 1 |
1 other study(ies) available for plerixafor and Rhabdomyosarcoma 2
Article | Year |
---|---|
Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
Topics: Animals; Benzylamines; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Chemokine CXCL11; Chemokine CXCL12; Cyclams; Down-Regulation; Endothelial Cells; Fibronectins; Heterocyclic Compounds; Humans; Matrix Metalloproteinases; Mice; Mice, SCID; Oligopeptides; Pertussis Toxin; Phosphorylation; Receptors, CXCR; Receptors, CXCR4; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Tissue Inhibitor of Metalloproteinases | 2010 |